13/09/2026
Great to see Gail and the team at trying out NESA XSignal® at the Health Optimisation Summit in London today.
Gail and her team work with patients living with dysautonomia, where dysfunction of the autonomic nervous system (ANS) can affect everything from heart rate and blood pressure to sleep, energy, digestion and the ability to cope with everyday stressors.
That’s what makes the potential of NESA XSignal so interesting.
NESA uses non-invasive neuromodulation technology designed to help regulate the autonomic nervous system, supporting the body’s ability to move towards a more balanced state.
With a growing evidence base, including over 16 randomised controlled trials, we’re particularly interested in what this could mean in clinical practice.
For patients with autonomic dysfunction, better regulation of the ANS could potentially mean improved sleep, greater resilience, better recovery and, ultimately, an improvement in quality of life.
It was fantastic to let Gail experience the technology first-hand today and to discuss where neuromodulation could fit into the future of patient care.